E-PHARMA ALWAYS TO CREATE SOLUTIONS Trademark

Trademark Overview


On Friday, March 10, 2017, a trademark application was filed for E-PHARMA ALWAYS TO CREATE SOLUTIONS with the United States Patent and Trademark Office. The USPTO has given the E-PHARMA ALWAYS TO CREATE SOLUTIONS trademark a serial number of 79222937. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, June 27, 2025. This trademark is owned by E-PHARMA TRENTO S.p.A.. The E-PHARMA ALWAYS TO CREATE SOLUTIONS trademark is filed in the Treatment & Processing of Materials Services, Computer & Software Services & Scientific Services, and Pharmaceutical Products categories with the following description:

Processing of chemical and/or pharmaceutical substances into effervescent tablets, granulated effervescent preparations, orally disintegrating tablets, orally disintegrating granules, soluble granules, granules for suspension, chewable tablets

Pharmaceutical preparations for the treatment of anemia, cold and flu, gastro-intestinal diseases, osteroporosis, respiratory diseases, for use in urology, gynecological disease, central nervous system and for pain relief and food supplement in the form of effervescent tablets and/or granulated effervescent preparations manufactured on behalf on third parties; pharmaceutical preparations for the treatment of anemia, cold and flu, gastro-intestinal diseases, osteroporosis, respiratory diseases, for use in urology, gynecological disease, central nervous system and for pain relief and food supplement in the form of orally disintegrating tablets and orally disintegrating granules and soluble granules manufactured on behalf of third parties; pharmaceutical preparations for the treatment of anemia, cold and flu, gastro-intestinal diseases, osteroporosis, respiratory diseases, for use in urology, gynecological disease, central nervous system and for pain relief and food supplement in the form...

Research and development of pharmaceutical preparations and food integrators in the form of effervescent tablets, granulated effervescent preparations, orally disintegrating tablets, orally disintegrating granules, soluble granules, granules for suspension, chewable tablets; scientific and industrial research in the field of chemistry and pharmacology; scientific analytical laboratory services; chemical research and analysis
e-pharma always to create solutions

General Information


Serial Number79222937
Word MarkE-PHARMA ALWAYS TO CREATE SOLUTIONS
Filing DateFriday, March 10, 2017
Status709 - CANCELLED - SECTION 71
Status DateFriday, June 27, 2025
Registration Number5624713
Registration DateTuesday, December 11, 2018
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, September 25, 2018

Trademark Statements


Goods and ServicesProcessing of chemical and/or pharmaceutical substances into effervescent tablets, granulated effervescent preparations, orally disintegrating tablets, orally disintegrating granules, soluble granules, granules for suspension, chewable tablets
Description of MarkThe mark consists of the stylized wording "E-PHARMA" in the color light blue placed above the stylized wording "ALWAYS TO CREATE SOLUTIONS" in the color white and enclosed in a light blue bar.
Goods and ServicesPharmaceutical preparations for the treatment of anemia, cold and flu, gastro-intestinal diseases, osteroporosis, respiratory diseases, for use in urology, gynecological disease, central nervous system and for pain relief and food supplement in the form of effervescent tablets and/or granulated effervescent preparations manufactured on behalf on third parties; pharmaceutical preparations for the treatment of anemia, cold and flu, gastro-intestinal diseases, osteroporosis, respiratory diseases, for use in urology, gynecological disease, central nervous system and for pain relief and food supplement in the form of orally disintegrating tablets and orally disintegrating granules and soluble granules manufactured on behalf of third parties; pharmaceutical preparations for the treatment of anemia, cold and flu, gastro-intestinal diseases, osteroporosis, respiratory diseases, for use in urology, gynecological disease, central nervous system and for pain relief and food supplement in the form of granules for suspension and chewable tablets manufactured on behalf of third parties
Indication of Colors claimedThe color(s) light blue and white is/are claimed as a feature of the mark.
Goods and ServicesResearch and development of pharmaceutical preparations and food integrators in the form of effervescent tablets, granulated effervescent preparations, orally disintegrating tablets, orally disintegrating granules, soluble granules, granules for suspension, chewable tablets; scientific and industrial research in the field of chemistry and pharmacology; scientific analytical laboratory services; chemical research and analysis

Classification Information


International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, June 27, 2025
Primary Code040
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, June 27, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, June 27, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameE-PHARMA TRENTO S.p.A.
Party Type30 - Original Registrant
Legal Entity Type09 - Joint Stock Company
AddressIT

Party NameE-PHARMA TRENTO S.p.A.
Party Type20 - Owner at Publication
Legal Entity Type09 - Joint Stock Company
AddressIT

Party NameE-PHARMA TRENTO S.p.A.
Party Type10 - Original Applicant
Legal Entity Type09 - Joint Stock Company
AddressIT

Trademark Events


Event DateEvent Description
Tuesday, December 19, 2017APPLICATION FILING RECEIPT MAILED
Thursday, December 14, 2017SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, December 15, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, December 15, 2017ASSIGNED TO EXAMINER
Wednesday, January 3, 2018REFUSAL PROCESSED BY MPU
Wednesday, January 3, 2018NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, December 21, 2017NON-FINAL ACTION WRITTEN
Friday, December 22, 2017NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, August 20, 2018ASSIGNED TO LIE
Wednesday, September 5, 2018NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, September 5, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, September 5, 2018NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Friday, September 21, 2018NOTIFICATION PROCESSED BY IB
Friday, January 19, 2018REFUSAL PROCESSED BY IB
Monday, July 2, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, July 2, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, July 3, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, August 7, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, September 25, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 11, 2018REGISTERED-PRINCIPAL REGISTER
Monday, March 11, 2019FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, March 19, 2019FINAL DISPOSITION NOTICE SENT TO IB
Friday, April 5, 2019FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, December 11, 2023COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Friday, June 27, 2025CANCELLED SECTION 71
Tuesday, March 19, 2019FINAL DISPOSITION PROCESSED
Tuesday, September 25, 2018PUBLISHED FOR OPPOSITION